InsidersTradesSigma
Track the 셀레믹스 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 셀레믹스 has logged 26 reports. Market capitalisation: €157.1bn. The latest transaction was filed on 16 July 2026 (Purchase). Among the most active insiders: 김효기. The full history is accessible without an account.
21
Insider Decl.
n/a
Thresholds
€9m
6 ops.
Buy Volume
€1m
6 ops.
Sell Volume
4Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,529 of 29,063 companies
27.2
score / 100
Value28
Quality27
FCF yld-2.4%
Earn yld-2.6%
EV/EBITDA·
ROE-37%
Gross mgn50%
Net mgn-70%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 July 2026
Declarations26 total
Other
Other
Other
Other
Other
1,021,143 shares13.83% mcapKRXDART:20260507000371
ShareKRXDART:20260507000379
25 of 26 declarations
关于 셀레믹스
셀레믹스 是一家在 XKRX 市场上市的医疗保健和制药公司。它专注于开发疾病诊断和治疗的创新解决方案。